XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents (includes restricted cash of $1,855 at December 31, 2023) $ 127,954 $ 136,964
Accounts receivable, net of allowances of $860 and $1,118 at June 30, 2024 and December 31, 2023, respectively 16,301 18,264
Prepaid expenses 6,895 6,067
Other current assets 2,753 1,787
Total current assets 153,903 163,082
Property and equipment, net 16,946 18,880
Operating lease right-of-use assets 3,019 10,132
Intangible assets, net 5,170 8,375
Other assets 3,976 3,851
Total assets 183,014 204,320
Current liabilities    
Accounts payable 9,082 6,875
Accrued employee expenses 3,504 6,667
Operating lease liabilities, current 2,080 3,240
Accrued expenses and other current liabilities 14,195 12,196
Total current liabilities 28,861 28,978
Operating lease liabilities, net of current portion 9,922 11,169
Other Liabilities, Noncurrent 347 3,958
Total liabilities 39,130 44,105
Commitments and contingencies (Note 5)
Stockholders’ Equity    
Preferred stock — $0.0001 par value; 20,000,000 shares authorized at June 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding at June 30, 2024 and December 31, 2023 0 0
Common stock — $0.0001 par value; 1,000,000,000 shares authorized at June 30, 2024 and December 31, 2023, respectively; 92,023,984 and 91,091,541 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 9 9
Additional paid-in capital 725,541 722,504
Accumulated deficit (581,666) (562,298)
Total stockholders’ equity 143,884 160,215
Total liabilities and stockholders’ equity $ 183,014 $ 204,320